- Home
- KALA vs CHR Comparison
KALA vs CHR Comparison
Compare KALA & CHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALA
- CHR
- Stock Information
- Founded
- KALA 2009
- CHR 2016
- Country
- KALA United States
- CHR China
- Employees
- KALA 43
- CHR N/A
- Industry
- KALA Biotechnology: Pharmaceutical Preparations
- CHR EDP Services
- Sector
- KALA Health Care
- CHR Technology
- Exchange
- KALA Nasdaq
- CHR Nasdaq
- Market Cap
- KALA 27.3M
- CHR 26.1M
- IPO Year
- KALA 2017
- CHR N/A
- Fundamental
- Price
- KALA $5.92
- CHR $2.53
- Analyst Decision
- KALA Strong Buy
- CHR
- Analyst Count
- KALA 2
- CHR 0
- Target Price
- KALA $15.00
- CHR N/A
- AVG Volume (30 Days)
- KALA 31.3K
- CHR 269.0K
- Earning Date
- KALA 11-12-2024
- CHR 07-31-2024
- Dividend Yield
- KALA N/A
- CHR N/A
- EPS Growth
- KALA N/A
- CHR N/A
- EPS
- KALA N/A
- CHR 3.44
- Revenue
- KALA N/A
- CHR $155,947,000.00
- Revenue This Year
- KALA N/A
- CHR N/A
- Revenue Next Year
- KALA N/A
- CHR N/A
- P/E Ratio
- KALA N/A
- CHR $0.74
- Revenue Growth
- KALA N/A
- CHR 0.88
- 52 Week Low
- KALA $4.21
- CHR $2.18
- 52 Week High
- KALA $9.25
- CHR $3.90
- Technical
- Relative Strength Index (RSI)
- KALA 41.69
- CHR 38.69
- Support Level
- KALA $5.67
- CHR $2.56
- Resistance Level
- KALA $6.23
- CHR $2.71
- Average True Range (ATR)
- KALA 0.31
- CHR 0.23
- MACD
- KALA -0.07
- CHR -0.03
- Stochastic Oscillator
- KALA 21.55
- CHR 3.16
About KALA KALA BIO Inc.
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.
About CHR Cheer Holding Inc.
Cheer Holding Inc is a provider of next generation mobile internet infrastructure and platform services in China. It is engaged in building a digital ecosystem that integrates platforms, applications, technology, and industry into a cohesive system, thereby creating a new, open business environment that leverages AI technology. Its portfolio includes various products and services, such as Polaris Intelligent Cloud, CHEERS Telepathy, CHEERS Open Platform, CHEERS Video, CHEERS e-Mall, CheerReal, CheerCar, CheerChat, CHEERS Fresh Group-Buying E-commerce Platform, Digital Innovation Research Institute, CHEERS Livestreaming, variety show series, IP short video matrix, and more.